RealTime SARS-CoV-2 EUA

2020: Abbott urgently permitted to deliver tests for a coronavirus

In the middle of March, 2020 the Abbott company got the emergency permission of regulatory bodies to deliveries of the molecular test for a new coronavirus (COVID-19).

The company stated that it will immediately send 150,000 RealTime SARS-CoV-2 EUA tests to the clients to the USA. Medics will be able to use tests on the RealTime system of Abbott m2000 company, and Abbott promises to unroll the additional systems of m2000 system if necessary.

Abbott got the emergency permission of regulatory bodies to deliveries of the molecular test for a new coronavirus (COVID-19)

In the USA more than 175 m2000 systems which are capable to execute up to 470 tests within 24 hours are applied. Abbott purpose — to provide up to 1 million tests for a coronavirus a week. The representative of the company confirmed that tests will go to hospitals and the medical centers in 18 states, including three most victims of a pandemic — Washington, California and New York.

The global problem, such as coronavirus, requires commitment and cooperation of all who are capable to help with its solution — the CEO of Abbott Miles White in the press release announced. — I am proud of the Abbott command and what they could reach for such short period, and I want to thank administration and regulatory bodies for cooperation at achievement of an effective objective.

Earlier regulatory bodies of the USA also issued the emergency permissions to production of COVID-19 tests to two other companies - the Massachusetts Thermo Fisher Scientific and the Swiss pharmaceutical firm Roche. The Thermo Fisher Scientific company reported that it is ready to provide 1.5 million tests and is going to increase quickly production to 2 million tests a week, and in April — up to 5 million tests a week. These tests should vosplonit spaces in diagnostic opportunities of hospitals which seriously limit capability of the USA to monitor distribution of COVID-19.^[1]

Notes